Aurora Cannabis Inc. (ACB)

5.02
NYSE : Process Industries
Prev Close 5.16
Day Low/High 4.92 / 5.10
52 Wk Low/High 4.58 / 12.53
Avg Volume 12.71M
Exchange NYSE
Shares Outstanding 1.01B
Market Cap 5.29B
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Cronos Jumps on Double Upgrade, Tilray Initiated With Perform Rating

Cronos Jumps on Double Upgrade, Tilray Initiated With Perform Rating

Bank of America lifts its price target on Cronos to $20 from $13.

Stocks Under $10 Weekly Summary

During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.

Cannabis Stocks Lower as FDA Hearing on CBD-Infused Foods Gets Underway

Cannabis Stocks Lower as FDA Hearing on CBD-Infused Foods Gets Underway

The FDA will discuss the safety and product quality of CBD-derived compounds in a public hearing Friday.

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

Ben & Jerry's Wants to Get in on CBD Craze

Ben & Jerry's Wants to Get in on CBD Craze

The company's announcement comes ahead of an FDA's public hearing on the legalization of CBD-infused foods and beverages on Friday.

Stocks Under $10 Weekly Summary

Several positive moves along with our cash position helped insulate the overall portfolio’s performance from last week's market decline.

A Holding With a Fighting Chance to Score a Knockout

Aurora Cannabis has reached an agreement with the UFC to study the effect of CBD-infused products on athlete recovery and wellness; we also glance at J.C. Penney post-earnings.

Aurora Cannabis Enters Partnership With UFC to Advance Marijuana Research

Aurora Cannabis Enters Partnership With UFC to Advance Marijuana Research

The partnership is a multi-year, multi-million dollar global research partnership that looks to establish a link between CBD products and athlete wellness and recovery.

Aurora Cannabis And UFC® Join Forces To Advance CBD Research, Education, And Product Development

Aurora Cannabis And UFC® Join Forces To Advance CBD Research, Education, And Product Development

Multi-Year Global Partnership will Advance Science on Athlete Health and Wellness NYSE: ACB   TSX:ACB            EDMONTON, May 21, 2019 /PRNewswire/ - Aurora Cannabis Inc.

Stocks Under $10 Weekly Summary

Amid renewed trade and geopolitical tensions, we trimmed our position in Energy Recovery and added a short-term trade in J.C. Penney.

Aurora Cannabis Up 2.4%; Tera Tech Off 5.6%: Cannabis Stocks Mixed

Aurora Cannabis Up 2.4%; Tera Tech Off 5.6%: Cannabis Stocks Mixed

Gainers trail losers in Cannabis sector action Thursday.

Aurora Cannabis Up 3.6%, General Cannabis Off 2.9%; cbdMD Due to Report

Aurora Cannabis Up 3.6%, General Cannabis Off 2.9%; cbdMD Due to Report

Gainers lead losers a day after financial results from Aurora and Tilray.

Stocks Finish Higher For Second Day on Possible Delay of Auto Tariffs

Stocks Finish Higher For Second Day on Possible Delay of Auto Tariffs

Stocks end higher following a report that the Trump administration plans to delay auto tariffs for six months.

Trimming a Position and What to Make of an Earnings Report

Energy Recovery has stabilized above our target, warranting some action. Plus, Aurora Cannabis reports earnings.

Can Aurora Cannabis Go Higher Despite Earnings Miss?

Can Aurora Cannabis Go Higher Despite Earnings Miss?

Aurora Cannabis is well off the lows, but not posting a very big move on earnings. Here are the must-know breakout and breakdown levels to watch.

One Thing Investors Need to Know Before Investing in Cannabis

One Thing Investors Need to Know Before Investing in Cannabis

Action Alerts Plus senior analyst Jeff Marks has some advice for investors looking to invest in cannabis and what they should be watching.

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Curious about the cannabis sector? Here's what Tilray and Aurora's earnings mean for the sector.

What You Need to Know About the Markets, Macy's, Tilray, and Aurora Earnings

What You Need to Know About the Markets, Macy's, Tilray, and Aurora Earnings

Is the market oversold? What should investors need to know about Tilray, Aurora and Macy's earnings? Here's what investors need to know according to Action Alerts Plus senior analyst Jeff Marks and Real Money reporter Kevin Curran.

What Investors Need to Know About the Trade War, What It Means for Retail - LIVE

What Investors Need to Know About the Trade War, What It Means for Retail - LIVE

It's time to tackle the markets, and earnings from Macy's, Tilray and Aurora. Join Katherine Ross, Jeff Marks and Kevin Curran as they discuss the biggest market headlines.

Tilray Shares Jump After Q1 Revenue Beat; Aurora Slides as Sales Miss Forecasts

Tilray Shares Jump After Q1 Revenue Beat; Aurora Slides as Sales Miss Forecasts

Tilray shares traded higher Wednesday after the Canadian cannabis group posted stronger-than-expected first quarter sales, while its domestic rival Aurora Cannabis slumped after its revenues missed analysts' forecast amid caps on retail store growth in the Canadian market.

Cisco, Tilray, Aurora Cannabis, Alibaba, Trade Talks - 5 Things You Must Know

Cisco, Tilray, Aurora Cannabis, Alibaba, Trade Talks - 5 Things You Must Know

U.S. stock futures decline though sentiment gets a lift from a softening of the rhetoric from Donald Trump in the U.S.-China trade war; Cisco, Alibaba and Macy's report earnings; Tilray shares rise after the Canadian cannabis company posts a revenue beat.

Aurora Cannabis Revenue Surges 367% to C$75 Million in Fiscal Third Quarter

Aurora Cannabis Revenue Surges 367% to C$75 Million in Fiscal Third Quarter

Canadian cannabis producer says loss attributable to shareholders was C$158 million.

Aurora Cannabis Announces Financial Results For The Third Quarter Of Fiscal 2019

Aurora Cannabis Announces Financial Results For The Third Quarter Of Fiscal 2019

Solid Net Revenue Growth Across All Channels to $65.1 Million Production Volumes Double While Per-Unit Production Costs Decline On Track to Deliver Positive EBITDA Beginning in Fiscal Q4 2019 TSX: ACB | NYSE: ACB EDMONTON, May 14, 2019 /PRNewswire/...

Stocks Rebound, Walmart, Roundup and Aurora Cannabis - 5 Things You Must Know

Stocks Rebound, Walmart, Roundup and Aurora Cannabis - 5 Things You Must Know

U.S. stock futures point to a modest rebound for Wall Street on Tuesday after markets reeled in the previous session as China retaliated in its trade war with the U.S.; Bayer's Monsanto loses $2 billion verdict in Roundup cancer trial; Walmart takes on Amazon with free, next-day delivery.

Stocks Under $10 Weekly Summary

We took some nice profits trimming a position, exited a name and added to another holding during a challenging week for stocks.

Aurora Cannabis Tumbles Ahead of Earnings Report

Aurora Cannabis Tumbles Ahead of Earnings Report

Aurora Cannabis shares are falling ahead of the release of the cannabis company's earnings report Tuesday.

Aurora Cannabis And Radient Technologies Announce First Commercial Delivery Of Cannabis Derivatives

Aurora Cannabis And Radient Technologies Announce First Commercial Delivery Of Cannabis Derivatives

Transformational Milestone for Radient, Increasing Aurora's Global Derivative Market Capacity Substantially TSX: ACB | NYSE: ACB, TSXV: RTI EDMONTON, May 13, 2019 /PRNewswire/ - Aurora Cannabis Inc.

Stocks Spring Back: Cramer's 'Mad Money' Recap (Friday 5/10/19)

Stocks Spring Back: Cramer's 'Mad Money' Recap (Friday 5/10/19)

The markets staged a big reversal Friday after the China tariffs and Uber's IPO thud. Jim Cramer's got your game plan for next week.

ADT, Domo, Aurora Cannabis: 'Mad Money' Lightning Round

ADT, Domo, Aurora Cannabis: 'Mad Money' Lightning Round

Jim Cramer takes a look at ADT, Domo, Aurora Cannabis, Seaspan, Walgreens Boots Alliance, Sirius XM Radio and more.

Cronos Falls Despite Swinging to Small First-Quarter Profit

Cronos Falls Despite Swinging to Small First-Quarter Profit

Cronos shares are falling despite easily topping analysts' earnings estimates.

TheStreet Quant Rating: C- (Hold)